Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
Clinical trial NCT00128895 · TERMINATED
Trial details
- NCT number
- NCT00128895
- Sponsor
- University Medical Center Groningen
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2014-06-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.